Reddit Posts
Emerging Biosolutions $EBS at $2, 20pct of Book Value; Ramping Up FDA approved NARCAN nasal spray
$EBS Buy this $2 BioTech supplier just ramping up sales of Narcan (Anti Opioid FDA approved Nasal Spray)
Narcan from $EBS approved by FDA as an OTC med; on Walgreen/CVS shelves in Sepgtember
FDA Approves NARCAN at $EBS; On Walgreen and CVS Shelves in September
Narcan was approved for over the counter. Will we see a squeeze for EBS?
FDA approves over the counter NARCAN.
Emergent Biosolutions (EBS): Last and Final Boarding Call
EBS has potential for a run this coming week
$EBS to be approved BY March 29th for NARCAN to be sold over the counter.
$EBS to be approved BY March 29th for NARCAN to be sold over the counter.
EBS , BHC , EBS are possible high day runners.
EBS update since my post 11d ago, and FDA ruling still pends on OTC Narcan.
$EBS Emergent BioSolutions stock
We got any thoughts on Emergent Biosolutions (EBS)?
CMRX has a strong chance at a significant jump due to the shortage of vaccines and the spread of Monkeypox. They make the pill. Short interest is high and just bounced off of an upward 30 day moving average. CMRX gets an extra 100 million for Tembexa from EBS if Biden obliges.
Monkey pox movers on possible US Public Health Emergency Declaration
Monkey pox movers on possible US Public Health Emergency Declaration news
$EBS and Monkey Pox- an update on earlier comments of few weeks ago
Emergent BioSolutions ($EBS): Biden's Coronavirus and Harris's major lobbyist.
From July 5th to today July 8th a total of 9014 cases of monkeypox has been identified globally $SIGA $CMRX $EBS $LH $ABT In my opinion cases will hit next week more than 15k+ internationally
From July 5th to today July 8th a total of 9014 cases of monkeypox has been identified globally $SIGA $CMRX $EBS $LH $ABT In my opinion cases will hit next week more than 15k+ internationally
$EBS Govt approved Vaccine supplier for SmallPox and MonkeyPox
Monkeypox is mutating fast $SIGA $CMRX $EBS
WHO will declare Monkeypox a PHEIC by Sunday $BAVA FINAL DD
WHO will make Monkeypox a PHEIC by Sunday $BAVA $BVNRY
MonkeyPox Outbreak - $EBS - Opportunity!
Monkeypox: a money making opportunity from the strangest timeline
Let's make monkeypox into a moneybox. $EBS, $SIGA
Let's make monkeypox to moneybox. $EBS, $SIGA
is monkeypox gonna monkeynut all over the world? if so: DD time
Monkey pox EBS gains 1k to 13k sold in a few days
EU Health Agency Advises Member States to Plan for Monkeypox Jabs
Original Monkeypox DD - Part 2 - Update and Outlook $EBS $BAVA
Original Monkeypox DD - Part 2 $EBS $BVNRY - Update and Outlook
Calls on Pharma Companies Focused on Vaccines & Therapeutics Against the Monkeypox Virus.
Monkeypox Case Reported in U.S. Emergent Biosolutions Inc (EBS) Makes a Vaccine. - Calls on Emergent Biosolutions
if you missed the COVID-19 run up on PFE or BNTX in 2020, don't miss this Monkey Pox play
EBS options, Monkeypox vaccines being made. Get it while it's still hot
Monkeypox is a thing, I don't want it to be a thing but it is. Lets make money on it.
Monkeypox - What You Need To Know $EBS $BVNRY
MonkeyPox - What You Need To Know $EBS $BVNRY
Managing an Evolving Workforce Creates Challenges and Golden Star Enterprises (GSPT) Offers a Popular Solution. Recently signed contracts and LOI's
Life saving opioid overdose "antidote" Naloxone: demand & profitability EBS (Cynical DD/Shitpost?)
Life saving opioid overdose "antidote" Naloxone: demand & profitability EBS/HKMPY (Cynical DD/Shitpost?)
Life saving opioid overdose "antidote" Naloxone: demand & profitability EBS/EKMPY (Cynical DD/Shitpost?)
Incredible lifesaving opioid overdose/poisoning antidote Naloxone EBS/HKMPY DD (Serious Shit)
$EBS: From $127.20 on February to $32.63 today!
Emergent Biosolutions (EBS), producer of Covid-19 immune globin therapy which began study for 800 patients last week. Current price $64, price target $92.
Emergent Biosolutions (EBS), producer of Covid-19 immune globin therapy which began study for 800 patients last week. Current price $64, price target $92.
Straight from the horses mouth, a look at fines levied against Citadel and their correlation to what’s happening now. And when is the mentality “slap on the wrist” going to become 10-25yr sentence.
EVIL PEOPLE ARE TRYING TO KILL EMERGENT BIOSOLUTIONS AND THAT WILL KILL PEOPLE
[$NOK]🚀🌕 Why Nokia is massivly underated! 🚀🌕$10+
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
My $23k bet on a big EBS bounce after JNJ vaccine issues are ironed out
EBS down 13%, what do you guys will happen to this stock?
Mentions
I can understand that but my view is the the distance EBS can r Travel is much higher given how undervalued it is The only issue is no one gives them their flowers But they continue to only improve so I feel safe I saw this go from 12 to 2 and now it hit 15 and 13 after 20 wouldn't shock me Buyouts at 25+ wouldn't either
I feel like my money is stuck with EBS and if I am better off putting it in AMD or the likes
The other 11 over the News: BNP.France BNVA.Spain EBS.Austria ROG.Swistzerland Enel.Italy Ora.France BA.UK SAF.France LDO.Italy ASML.Netherlands IFX.Germany
I think of PLTR as the government’s version of SAP or Oracle E-Business Suite, just built with modern tech. Palantir has “modules” the same way SAP has Finance, Controlling, Materials Management, Production Planning, etc. And in the same way SAP runs order-to-cash, Palantir runs mission-system defence workflows—intelligence collection all the way through the head-spaghetti decision chain. Once an organisation adopts something like SAP or EBS, the system ends up running the business. The vendor can charge whatever they want, slap on bullshit licensing rules (Oracle on VMware…), and you’ll never pull it out. You’ve got a better chance separating shit from toilet paper than ripping out SAP or EBS once the company relies on them. Same logic applies to PLTR. People have wild ideas about PLTR because they have no idea what ERP is or why it exists. And honestly, plenty of ERP consultants only know their own module. Yet the largest companies on the planet don’t magically self-assemble like Autobots; they run on thousands of coordinated inputs. For something like 5G vaccines you need chips from Qualcomm, antennas from Nokia, vaccines from Pfizer, QA from another supplier, autism from WSB, etc. All of it has to turn up in the right place at the right time. To run a business like this you either have to be autistic or implement software to run your operation. For traditional ERP use cases give ze Germans a call, for defence shit call Alex Karp. I think Karp leans into the Bruce Wayne persona intentionally. He picked woke lefties as his enemy because it sells well with traditional defence buyers. The US Defence, sorry, War Department have a nearly $1T dollar budget, they’re the people you have to appeal to.
Lol it’s not done because of that. It’s just time because of poor EPS growth rate in the future. They have projected about 7% EBS growth threat for next four years. They simply cannot stay above 20 PE with that kind of growth rate.
It’s in the last image, CSIQ and EBS
Congrats! Those EBS calls are printing hard, and I believe this is the beginning of a huge squeeze.
that EBS call should be pretty valuable right about now
i feel you. i own RDDT, FIG and EBS. very bad day.
emergent biosolutions ($EBS)
Part 1: "Why would hyperscalers spend so much with $ORCL instead of just spending themselves?" You're missing the strategic point about AI and it explains why hyperscalers engage with ORCL. It's about the data. The value of AI isn't "Data in general." It's \*corporate data.\* Any LLM can build something that scours the internet and learns everything publicly available. That's table stakes for AI. What value add/competitive advantage any given LLM has is the ability to take a company's private data and refine the results of public data to give the user more specific context to the results of a query. For the most part, \*where\* is that corporate data? The data that runs businesses, keeps people out of jail, meets regulatory requirements for auditing, governance, etc put out by nation states GDPR, industries (PCI /DSS) and governments (Sarb-OX)? Most of it is in Oracle databases and Oracle applications (both on-premise and in SaaS). And where is it going? If not staying in Oracle Databases, it'll move to Oracle SaaS. AWS and GCP in particular don't have any play in that market -- they are infrastructure providers. In the near term, their customers can put the Oracle databases on their compute, but they mostly all want to move to SaaS because they don't want be in the application administration business. They just want to use the apps. GCP and AWS don't play in that space. ORCL does -- they have legacy and SaaS applications at the core of 100's of thousands of businesses between Oracle EBS, Fusion SaaS, Netsuite, and industry apps is Banking, Telecom, Retail Manufacturing, Supply Chain, Construction and Engineering, and a bunch more. They all use Oracle Database. Azure is a better position because they have some apps at the core of businesses like Dynamics 365, Exchange, Active Directory, Office, etc. But the BUSINESS data of the world is mostly in Oracle. This private data enhances the ability of an LLM to provide targeted, useful results. AWS, GCP and Azure all have infra that can run an Oracle DB, but relatively speaking, it runs like poorly. (anybody who argues that; well the proof is in the pudding: Why is Oracle on Exadata being offered in GCP and Azure, for one, and even more, why is AWS offering Oracle on Exadata when they have RDS Oracle?) All their customers are asking for better. They only solution is to go Oracle and get the Exadata -- so they are. They want that enterprise data too and if Oracle runs poorly in their cloud, they won't get it.
It was very random to me as well, but since biotechs are volatile it makes sense to stir some drama and then profit from it, that's what he did. I read some articles and all the negative arguments against atyr were dubious and one sided, so I'd call bs on it, also ever since that short attack the bears have been real quiet. I'd say taking everything into account, the science, the trial results so far, the invitation to EBS, the positive opinions of the particants of the trials, the recent job postings on atyr, etc, everything points to a positive direction
GAMB, EBS , and maybe PEW but not certain on that one
Made $2k off paper hands trades when EBS, CELH, PBPB, CASY, HIMS when long plays netted 40K 🥹
Cracking effort mate. I'm just in EBS but after listening to the Q25 call it seems like a pretty damn good investment. Either short or longer term. The longer could bring enormous gains.
$EBS UP 6+% After being kept low for days and weeks. MM manipulation. Short Squeeze Incoming. This will hit double digits with ease if the squeeze happens. It damn should. 💥💥 Good write up. Fingers crossed on financials.
$EBS looks to be like a 3 year play Could be sooner ofc due to bull runs from new drug releases or new orders from foreign countries But it also could be a buyout Solid and my favorite play for a long time
$EBS. Still time be for the pump gets really started.
I'm here for the next one But could you look into $EBS It's a non -traditional squeeze But there is a lot of shorting recently but the company has only posted Ws recently slowly climbing up
EBS - Emergent Bio solutions Lady walked into work, said many places will start carrying NARCAN. Was $2 at the time waited and it dropped to $1.50 and I bought. Shot up to $15, been stabilizing since then. Long term hold.
RKLB and EBS where my best ones
I'm a little late in responding to this. But I built up a fairly sizeable position (for me) back in April. I've been watching EBS for a long time and actually - for once - was somewhat able to time the bottom. My cost basis is around $5/share and as of today I'm up about 45%. I don't plan on selling anytime soon because, I, like you, see this going up to \~$15/share. I'll sell once we get there. EBS is never going to be a 50 billion dollar company. But I do think they can get to 1 to 2 billion. The fact that they're now in the Russell 2000 is telling. They make very good products but were terribly mismanaged for several years. I'm very bullish.
are you in for swing trades? or do you believe in EBS? And why not further out given it's EBS?
EBS always jumps when bombs star falling… I placed two calls this morning
Biggest loss on bag holding EBS of < 10k but biggest screw up was selling 690 shares of HIMS at $34
Is Five9 a good long term stock? I'm a high risk gambler from the U.S., late 40s, employed, and looking to cash out in 10 yrs. I also own EBS, Lucid, Indi, and Peabody. I'm done with short terms.
i didn't use a screener. it's a company that i've just been keeping an eye on and researching since they had a massive dump last year. Emergent Biosolutions (EBS). they're the manufacturer of a drug called Narcan. they were horribly mismanaged for a couple years and appear to be slowly turning it around and rebuilding.
Watchlist today for me will be EBS/ AMPG
I know I'm late to the game here... I've been watching EBS since last August when they had the massive sell off. I dabbled briefly but sold for a loss shortly afterward. I've been watching the company ever since. A couple weeks ago I stumbled across your post here while doing some recon on the company. Based on your post here I decided to buy in. I managed to DCA down to a cost basis right around $5.00. The earnings report yesterday was very strong and I'm really happy I took the risk of investing while it was down. Everything I've read (including your commentary here) gives me optimism that Emergent is heading in the right direction. I just wanted to say thank you for making this post last month and providing a very compelling argument. I hope your company continues to move in the right direction.
a couple weeks ago I bought shares in Emergent Biosolutions (EBS). been following this stock for a while now. Down *bad*. Did basically no research on the company other than watching stock price for long time. somehow I'm up 10% on this thing. lol. gonna continue holding just for fun and see what happens
so what do we think of emergent biosolutions (EBS)? or am i gonna get banned for even mentioning their existence
In the last week and a half I've purchased and held shares of WMT, RDDT and EBS. I've also bought and sold (for profit) USAR and IAU.
Your post with title "EBS Emergent BioSolutions" has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
Emergent Biosoluions (EBS). Yea or Nay?
I buy it on the EBS Swiss stock exchange with global trading on IBKR (ZURN). Dividends in Swiss Franc, only pain is that you need to fill out a form 82-I to get the amount the Swiss gov withholds as anticipatory tax back.
Or just buy Swiss franc directly on IBKR. 2 dollars per transfer. I actually used it as an opportunity to get some defensive Swiss stocks on EBS like Nestle and Roche. Just enable forex and global trading on your account. Also bought some IAU and have been slowly adding. Of course while also DCA SPY in case this is just a blip long term.
without a doubt $EBS fell from RFK concerns (no actual effect on us) monkeypox is spreading and we have the vax and the therapeautic is on the way we have plenty of other products but the biggest one is naxolone OTC Narcan this play has been beaten down way past it's asset value
Trade wasn't USD settled 95 years ago. Look at Russia and Pakistan settling via barter due to an inability to access USD. They were literally settling trade via Tangerines last fall. Anyone who thinks the world can survive without access to US markets is quite naive and uninformed as to how global trade actually functions and settles. Settling via gold isn't an option either. There simply isn't enough and the mechanisms for physical settlement aren't widely available anyway. You can guess which countries will capitulare first by looking at their currency liquidity profiles and if you can even trade them on primary FX markets like EBS and Reuters. If you can't trade them via a USD cross, they can't fight a tariff war with the US. Any country forced to replace lost dollars via fx transactions on the open market will end up devaluing their currency vs the USD offsetting inflation pressures on US consumers as well and negatively impacting their purchasing power for commoditie, which are both mostly dollar priced and settled. Next, look at which countries issue sovereign debt denominated in USD. They will also need access to US dollars and the most efficient and cost effective way is through direct trade with the US. Again, going to fx markets to purchase dollars only furthers the bid on USD and continues downward pressure on the local currency. Many countries will have to issue more debt simply to the purchase dollars necessary to pay their coupons. Finally, BRICS currencies have never been even a semi-serious option. Nearly none of the currencies are deliverable and the yuan is facing significant risk if China can't efficiently access US markets for trade as they'll end up with excess goods and a slowing economy from factory shutdowns. The assumption that demand curves are elastic and will fully absorb price increases is also mistaken. Significant price increases will result in demand reduction, which is going create even greater negative pressure on those countries that don't have the ability to easily source dollars. Anyone whose primary imports are discretionary items will really suffer. Think low cost TVs and other electronics. In the end, TINA to the USD when it comes to global trade settlement and this is why you won't see this administration back away from Tariffs. Trump may not be sharp but Bessent is a very intelligent macro trader and Lutnick has successfully built fx and cash bond trading platforms. Neither are naive to the mechanics of global capital flows and are well aware of how to leverage them to their advantage.
The issue is related to how RH generated their EBS. It doesn't necessarily mean that RH does not custody the assets. The bigger issue is that RH has incredibly poor risk management and poor quality control. That has always been true at RH. And you have to look at the totality of the issues at RH. This is not the first set of SEC administrative orders at RH. Also - deficient EBS reports is not a unique problem to RH. These types of issues can happen. And they do happen with other brokers as well. Record-keeping violations and customer disclosure violations are one of the most important activities that the SEC will look for. And for good reason.
Is the concern more about the not knowing who the UBO is or the lack of transactions transparency? Seems like most equity significant holdings would be picked up and reported in the appropriate jurisdictional reporting regime (US: 13D/G, 13F, EBS; UKI TOP, etc.). The amount of regulatory reporting done at an institutional level and on a global scale is nuts. I’d like to be helpful but I’m just not sure what else could be introduced to benefit the least sophisticated member of the investing public without more specific information.
Time to rotate back into penny stocks. SVRA and EBS down about 30-40% over 3 months and look for OSUR to top earnings next week
Is this the reason EBS dropped 14% today, starting at 11am? Since this isn’t new news, probably not? Was thinking of buying the dip. After hours has it back up over 4%.
Up +430% on EBS shares 2.02 avg should I continue to hold for long term?
Emergent Biosolutions (EBS) has Ebanga which is an Ebola vaccine. I’d imagine this outbreak is Marburg Virus which OraSure Technologies (OSUR) has an antigen test for. HODL’ing both positions long
I invested in EBS the first time this happened back in 2022: https://old.reddit.com/r/wallstreetbets/comments/uw9ehl/monkey_pox_ebs_gains_1k_to_13k_sold_in_a_few_days/
Emergent Biosolutions is the play, ticker EBS
All in on EBS after great earnings
EBS ticker. Beat the earnings extreme. So today will be funny.
TICK TOCK TIME IS UP! Q CLOCK ENDED THURS. 25 OCT. 2024 POTUS, EBS ALERT COUNTDOWN HAS BEGUN DEEP STATE ROTHSCHILD BANKING EMPIRE GOING DOWN, BANKS CLOSING BLACKOUT CONFIRMED LET'S START! 
EBS and ENVX about to dump bigly 
EBS holy fuck. Making MU look like a gain for ants
EBS, mpox just beginning
EBS gets a 400 million dollar mpox order (more than their entire market cap) and the stock is fucking red...what an absolute JOKE.
EBS, Mpox just beginning
EBS looks like it could be an easy short-squeeze play
Just buy EBS or WOK or something
EBS vaccine approval to be used for mpox. Hoping for a run up today for. Already +17% premarket. But I have a long way to go for my $20 9/20c to print
EBS gets mpox approval. I told yal to get on this shit weeks ago.
I was smart enough to buy EBS and LUNR. But dumb enough to be impatient and sold at loss.
EBS just got approval for a monkeypox vaccine and they are also the manufacturer or Narcan. 🚀
EBS just got FDA approval 🥲 at least theres something good this week for me
EBS - vaccine FDA approved
I'm down 11% on MRNA, EBS, and Novovax, but am confident that come election season, Monkeypox will be the new epidemic, so I'm looking for a large return on investment come November. I only have $400 in between all three conpanies, so I don't mind baghding until the next pandemic.
VRAX GOVX APDN have been volatile and surged up to 3 times. This seems to be the 3rd wave. Not that I am expert in day trading, but most of times as a pattern I have seen the 3rd or 4th wave to be last one. And often/sometimes it surges up again in the upcoming weeks. Here one factor is that Mpox is not a news that is going to fade away in a span of days. I would say it could take weeks or months for it to resolve. But I am unware of other factors that could drive the stock price of these mpox selling pharmas. Like I feel like the price of these stocks (EBS, VRAX, GOVX, APDN) is pumped up with mpox news but not sure abou the financials of them.
This isn't EBS so your gains are weak My $2 turned to $14 😎👍so I'm beating you percentage wise
EBS play for worldwide mpox epidemic come Christmas?
VRAX only manufactures testing kits, EBS smallpox vaccines
VRAX and EBS also have Vaccines that are helpful in MPOX cases.
Bullish on all MPOX stocks $VRAX $APDN $EBS $BAVA
Definitely EBS, GOVX, SIGA, maybe some VRAX and TNXP. They just dropped news that the new variant of monkeypox dropped in the US: [https://www.fox2detroit.com/news/mpox-wayne-county-health-department-confirms-first-case-since-2022](https://www.fox2detroit.com/news/mpox-wayne-county-health-department-confirms-first-case-since-2022)
Somehow at all day high returns, but it doesn't seem like it. Puts on EBS are paying nicely
YUP screwed my EBS gains too
EBS has now partnered with the WHO to address the MPOX situation, so I'm going to go all in on that. Furthermore some more RKLB 🚀🚀
I'm going to buy EBS calls immediately following an opening dip (if it comes) and sell the rip within 20 mins. Wish me luck.
Bought the top of EBS and GOVX just in time for the market to collectively decide it doesn’t care about mpox anymore 💪
EBS 
Whole portfolio up 6% today. Looking to diversify, buying more Nvidia before earnings, EBS call is very promising; up 100% already. Which plays are you going with? Might be too late for ASTS, might go bearish on SpaceX/TSLA as competitors get more attention. How long until EVs are profitable? Lexus and VW are working on their next-gen EV’s and I imagine that their established manufacturing and supply chains will give them a leg up against smaller competitors. Still holding RIVN in hopes that VW joint venture will push them up.
People would be slightly less rich than me if they followed my two EBS posts. Still has room to run to 15, not pumping just TA.
EBS is not beginning to grow fast. So check it.
CLOV has started to be profitable, good or bad but WSB picked this stock up and trading volume just massively increased the past week. Plus insider buying from the executives triggered a massive run. Be careful with FOMO, though. Still vulnerable to a big correction. Visit the CLOV page, this stock gained positive sentiments overall. Price target is way higher than the current levels. I exited half of my shares earlier today when it ran up to 18% from opening. lol. For EBS I do not have any DD on this. I just rode the monkeypox news last week. Pure speculative haha. Im currently up 28%. If I cross 30% Ill just close it. Same as RKLB, pure spec play. I just want to recoup my AMZN losses + cap gains from these trades and chill for a bit.
EBS is launching holy
Where is the **$EBS** post guy? 